Related Experiment Videos
Acute respiratory distress syndrome in children
F Beaufils1, J C Mercier, C Farnoux
1Hôpital Robert Debré, Service de Pédiatrie Réanimation, Faculté Xavier Bichat, Université Paris, VII, France.
Insights
Pediatric acute respiratory distress syndrome (ARDS) has high mortality, especially with cancer. Current treatments are supportive, focusing on mechanical ventilation, with emerging therapies needing more study.
Area of Science:
- Pediatrics
- Critical Care Medicine
- Respiratory Medicine
Background:
- Pediatric acute respiratory distress syndrome (ARDS) is a severe condition with high morbidity and mortality.
- Mortality rates exceed 50%, and over 80% in children with malignancies.
Purpose of the Study:
- To review current therapeutic interventions for pediatric ARDS.
- To discuss the role of conventional and emerging ventilation strategies.
- To highlight the potential of novel therapies and extracorporeal support.
Main Methods:
- Review of existing literature on pediatric ARDS management.
- Analysis of supportive care strategies, including mechanical ventilation.
- Evaluation of emerging technologies and alternative support methods.
Main Results:
- Conventional mechanical ventilation employs high positive end-expiratory pressure, low positive inspiratory pressure, and permissive hypercapnia.
- High-frequency oscillatory ventilation and tracheal insufflation offer less aggressive ventilation but are not widely used.
- Surfactant replacement, nitric oxide inhalation, and partial liquid ventilation show promise but require further clinical validation.
Conclusions:
- Therapeutic interventions for pediatric ARDS are primarily supportive.
- While novel therapies show potential, controlled clinical studies are essential for widespread adoption.
- Extracorporeal membrane oxygenation serves as a crucial alternative when conventional support fails.
Abstract:
The adult (acute) respiratory distress syndrome is a significant cause of morbidity in children. The mortality rates remain elevated, greater than 50%, and even greater than 80% in patients with underlying malignancies. The therapeutic interventions remain mainly supportive. Strategies of conventional mechanical ventilation are directed toward the use of high positive end-expiratory pressures, low positive inspiratory pressure, and permissive hypercapnia. High-frequency oscillatory ventilation and tracheal insufflation are not yet used extensively, although they should contribute to less aggressive ventilation. Surfactant replacement, nitric oxide inhalation, and partial liquid ventilation seem to be promising technologies, but controlled clinical studies are necessary before their wide-spread use. Extracorporeal membrane oxygenation remains the alternative technology in case of failure of conventional support.